ReviewDrug design, development and therapy2022

Disease Modifying Therapies for the Management of Children with Spinal Muscular Atrophy (5q SMA): An Update on the Emerging Evidence.

Helgi Thor Hjartarson et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.